Alexander SeifalianProf. Seifalian has worked at the Royal Free Hospital and University College London for over 26 years. He has also spent time at Harvard Medical School looking at causes of cardiovascular diseases and a year at Johns Hopkins Medical School looking attreatment of the liver. He has published more than 647 peer-reviewed research papers, and registered 14 UK and International patents. In 2007, he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards' Winner of Most Innovative New Product 2012 for the "synthetic trachea". Prof. Seifalian won the Nanosmat Prize in 2013, and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. Prof. Seifalian is currently working on the development and commercialisation of human organs using graphene based nanocomposite materials and stem cells technology. Read More Read Less